Aclarion vs Sera Prognostics
Aclarion and Sera Prognostics are similar in size: $75,730 and $81,000 of revenue in their latest fiscal years. Aclarion grew faster (65.6% against 5.2%). Aclarion kept more of each dollar of sales as profit: a net margin of -9551.9% against -39417.3%. Aclarion carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | AclarionACON, 2025 | Sera PrognosticsSERA, 2025 |
|---|---|---|
| Revenue | $75,730 | $81,000 |
| Revenue growth | 65.6% | 5.2% |
| Net income | −$7.2m | −$31.9m |
| Operating margin | -9312.5% | -45066.7% |
| Net margin | -9551.9% | -39417.3% |
| Return on equity | -104.8% | -51.8% |
| Free cash flow | −$7.2m | −$26.3m |
| Cash | $12.0m | $3.9m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 11 | 72 |
| Market value | $4.4m | $100m |
| Price vs our value range | — | — |
| Moat score | 8 (Weak) | 12 (Weak) |
| Insider trades, 12 months | 11 buys, 0 sales | 0 buys, 52 sales |